Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression

MP Hengartner, M Plöderl - BMJ evidence-based medicine, 2022 - ebm.bmj.com
The efficacy of antidepressants in the acute treatment of moderate-to-severe depression
remains a controversial issue. The minimal important difference (MID) is relevant to judge …

[HTML][HTML] Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta …

MP Hengartner, JC Jakobsen, A Sørensen, M Plöderl - PLoS One, 2020 - journals.plos.org
Background It has been claimed that efficacy estimates based on the Hamilton Depression
Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the …

One (effect) size does not fit at all: interpreting clinical significance and effect sizes in depression treatment trials

F Hieronymus, S Jauhar… - Journal of …, 2020 - journals.sagepub.com
The efficacy of antidepressants in major depressive disorder has been continually
questioned, mainly on the basis of studies using the sum-score of the Hamilton Depression …

Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression

G Isacsson, M Adler - Acta Psychiatrica Scandinavica, 2012 - Wiley Online Library
Isacsson G, Adler M. Randomized clinical trials underestimate the efficacy of
antidepressants in less severe depression. Objective: Demonstrating the superiority of …

Heterogeneity of outcome measures in depression trials and the relevance of the content of outcome measures to patients: a systematic review

C Veal, A Tomlinson, A Cipriani, S Bulteau… - The Lancet …, 2024 - thelancet.com
Research waste occurs when randomised controlled trial (RCT) outcomes are
heterogeneous or overlook domains that matter to patients (eg, relating to symptoms or …

Can effects of antidepressants in patients with mild depression be considered as clinically significant?

U Hegerl, AK Allgaier, V Henkel, R Mergl - Journal of affective disorders, 2012 - Elsevier
BACKGROUND: How to define clinical significance of antidepressants has become a matter
of far-reaching clinical and regulatory consequences. A mean difference of at least 3 points …

Minimally important differences and severity thresholds are estimated for the PROMIS depression scales from three randomized clinical trials

K Kroenke, TE Stump, CX Chen, J Kean, MJ Bair… - Journal of affective …, 2020 - Elsevier
Abstract Background Patient Reported Outcomes Measurement Information Systems
(PROMIS) scales are increasingly being used to measure symptoms in research and …

The clinical relevance of changes in the Montgomery–Asberg Depression Rating Scale using the minimum clinically important difference approach

G Duru, B Fantino - Current medical research and opinion, 2008 - Taylor & Francis
Objective: To identify the minimal clinically important difference (MCID) for the Montgomery–
Asberg Depression Rating Scale (MADRS) in randomised studies of depression, and to …

What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A …

HE Pigott, T Kim, C Xu, I Kirsch, J Amsterdam - BMJ open, 2023 - bmjopen.bmj.com
Objective Reanalyse the patient-level data set of the Sequenced Treatment Alternatives to
Relieve Depression (STAR* D) study with fidelity to the original research protocol and …

[HTML][HTML] Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials

C Bauer-Staeb, DZ Kounali, NJ Welton, E Griffith… - Journal of Clinical …, 2021 - Elsevier
Objective Previous research on the minimal clinically important difference (MCID) for
depression and anxiety is based on population averages. The present study aimed to …